Autoimmune Thyroid Diseases

Publikationsverlauf

Eingereicht: 17. Juli 2015

Angenommen: 17. Juli 2015

Artikel online veröffentlicht:
11. September 2015

• References

• 1 McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012; 42: 252-265
• 2 Rosenblum MD, Remedios KA, Abbas AK. Mechanisms of human autoimmunity. J Clin Invest 2015; 125: 2228-2233
• 3 Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nature Revs Endocrinol 2013; 9: 277-287
• 4 Bernecker C, Ostapczuk M, Vordenbäumen S, Ehlers M, Thiel A, Schinner S, Willenberg H, Scherbaum WA, Schott M. HLA-A2 phenotype may be protective against Graves’ disease but not against Hashimoto’s thyroiditis in Caucasians. Horm Metab Res 2013; 45: 74-77
• 5 Bernecker C, Halim F, Haase M, Willenberg HS, Ehlers M, Schott M. MicroRNA expressions in PMBCs, CD4 +, and CD8+T-cells from patients suffering from autoimmune Addison's disease. Horm Metab Res 2013; 45: 599-604
• 6 Ruffilli I, Ferrari SM, Colaci M, Ferri C, Fallahi P, Antonelli A. IP-10 in autoimmune thyroiditis. Horm Metab Res 2014; 46: 597-602
• 7 Dittmar M, Woletz K, Kahaly GJ. Reduced DNASE1 gene expression in thyroid autoimmunity. Horm Metab Res 2013; 45: 257-260
• 8 Ajjan RA, Weetman AP. The pathogenesis of Hashimoto’s thyroiditis: further developments in our understanding. Horm Metab Res 2015; 47: 702-710
• 9 Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S. Hashimoto’s thyroiditis: celebrating the centennial through the lens of the John Hopkins hospital surgical pathology records. Thyroid 2013; 23: 142-150
• 10 Weetman AP. The immunopathogenesis of chronic autoimmune thyroiditis one century after Hashimoto. Eur Thyroid J 2012; 1: 243-250
• 11 Bluestone JA, Bour-Jordan H, Cheng M, Anderson M. T cells in the control of organ specific autoimmunity. J Clin Invest 2015; 125: 2250-2260
• 12 Grant CR, Liberal R, Mieli-Vergani G, Vergani D, Longhi MR. Regulatory T cells in autoimmune disease: challenges, controversies and –yet-unanswered questions. Autoimmun Revs 2015; 14: 105-116
• 13 Kong YM, Brown NK, Morris GP, Flynn JC. The essential role of circulating thyroglobulin in maintaining dominance of natural regulatory T cell function to prevent autoimmune thyroiditis. Horm Metab Res 2015; 47: 711-720
• 14 Brix TH, Hegedus L. The complexicity of the etiology of autoimmune thyroid disease is gravely underestimated. Thyroid 2011; 21: 1289-1292
• 15 Duntas LH. The role of iodine and selenium in autoimmune thyroiditis. Horm Metab Res 2015; 47: 721-726
• 16 Morshed SA, Davies TF. Graves’ disease mechanisms: the role of stimulating, blocking and cleavage region TSH receptor antibodies. Horm Metab Res 2015; 47: 727-734
• 17 Furmaniak J, Sanders J, Núñez Miguel R, Rees Smith B. Mechanisms of action of TSHR autoantibodies. Horm Metab Res 2015; 47: 735-752
• 18 Pujol-Borrell R, Giménez-Barcons M, Marín-Sánchez A, Colobran R. Genetics of Graves’ disease: special focus on the role of TSHR gene. Horm Metab Res 2015; 47: 753-766
• 19 Piantanida E, Lai A, Sassi L, Gallo D, Spreafico E, Tanda ML, Bartalena L. Outcome prediction of treatment of Graves’ hyperthyroidism with antithyroid drugs. Horm Metab Res 2015; 47: 767-772
• 20 Bahn RS. Current insights into the pathogenesis of Graves’ ophthalmopathy. Horm Metab Res 2015; 47: 773-778
• 21 Salvi M, Campi I. Medical treatment of Graves’ orbitopathy. Horm Metab Res 2015; 47: 779-788
• 22 Neumann S, Place RF, Krieger CC, Gershengorn MC. Future prospects for the treatment of Graves’ hyperthyroidism and eye disease. Horm Metab Res 2015; 47: 789-796
• 23 Cho JH, Feldman M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med 2015; 21: 730-738
• 24 Wiesweg B, Johnson KT, Eckstein AK, Berchner-Pfannschmidt U. Current insights into animal models of Graves' disease and orbitopathy. Horm Metab Res 2013; 45: 549-555
• 25 Johnson KT, Wiesweg B, Schott M, Ehlers M, Müller M, Minich WB, Nagayama Y, Gulbins E, Eckstein AK, Berchner-Pfannschmidt U. Examination of orbital tissues in murine models of Graves’ disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissues. Horm Metab Res 2013; 45: 401-407
• 26 Banga JP, Moshkelgosha S, Berchner-Pfannschmidt U, Eckstein A. Modeling Graves’ orbitopathy in experimental Graves’ disease. Horm Metab Res 2015; 47: 797-803